Merck KGaA Statistics

Total Valuation

Merck KGaA has a market cap or net worth of EUR 69.80 billion. The enterprise value is 77.80 billion.

Market Cap	69.80B
Enterprise Value	77.80B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	Apr 29, 2024

Share Statistics

Merck KGaA has 434.78 million shares outstanding. The number of shares has increased by 0.00% in one year.

Shares Outstanding	434.78M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	16.54%
Float	129.19M

Valuation Ratios

The trailing PE ratio is 26.63 and the forward PE ratio is 17.39. Merck KGaA's PEG ratio is 2.36.

PE Ratio	26.63
Forward PE	17.39
PS Ratio	3.34
PB Ratio	2.44
P/FCF Ratio	28.76
PEG Ratio	2.36

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.26, with an EV/FCF ratio of 32.06.

EV / Earnings	29.63
EV / Sales	3.73
EV / EBITDA	15.26
EV / EBIT	22.78
EV / FCF	32.06

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 37.56.

Current Ratio	1.31
Quick Ratio	0.77
Debt / Equity	37.56
Debt / EBITDA	2.11
Debt / FCF	4.43
Interest Coverage	14.72

Financial Efficiency

Return on equity (ROE) is 9.51% and return on invested capital (ROIC) is 5.52%.

Return on Equity (ROE)	9.51%
Return on Assets (ROA)	4.33%
Return on Capital (ROIC)	5.52%
Revenue Per Employee	335,660
Profits Per Employee	42,235
Employee Count	62,176
Asset Turnover	0.42
Inventory Turnover	1.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.54% in the last 52 weeks. The beta is 0.71, so Merck KGaA's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+0.54%
50-Day Moving Average	166.14
200-Day Moving Average	157.89
Relative Strength Index (RSI)	38.46
Average Volume (20 Days)	271,869

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Merck KGaA had revenue of EUR 20.87 billion and earned 2.63 billion in profits. Earnings per share was 6.03.

Revenue	20.87B
Gross Profit	12.19B
Operating Income	3.42B
Pretax Income	3.26B
Net Income	2.63B
EBITDA	4.95B
EBIT	3.42B
Earnings Per Share (EPS)	6.03

Full Income Statement

Balance Sheet

The company has 2.82 billion in cash and 10.75 billion in debt, giving a net cash position of -7.93 billion or -18.25 per share.

Cash & Cash Equivalents	2.82B
Total Debt	10.75B
Net Cash	-7.93B
Net Cash Per Share	-18.25
Equity (Book Value)	28.62B
Book Value Per Share	65.85
Working Capital	3.12B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.21 billion and capital expenditures -1.78 billion, giving a free cash flow of 2.43 billion.

Operating Cash Flow	4.21B
Capital Expenditures	-1.78B
Free Cash Flow	2.43B
FCF Per Share	5.58

Full Cash Flow Statement

Margins

Gross margin is 58.42%, with operating and profit margins of 16.36% and 12.58%.

Gross Margin	58.42%
Operating Margin	16.36%
Pretax Margin	15.63%
Profit Margin	12.58%
EBITDA Margin	23.72%
EBIT Margin	16.36%
FCF Margin	11.63%

Dividends & Yields

This stock pays an annual dividend of 2.20, which amounts to a dividend yield of 1.37%.

Dividend Per Share	2.20
Dividend Yield	1.37%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	4
Payout Ratio	39.26%
Buyback Yield	-0.00%
Shareholder Yield	1.37%
Earnings Yield	3.76%
FCF Yield	3.48%

Dividend Details

Stock Splits

The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.

Last Split Date	Jun 30, 2014
Split Type	Forward
Split Ratio	2

Scores

Merck KGaA has an Altman Z-Score of 3.22.

Altman Z-Score	3.22
Piotroski F-Score	n/a